Weight Loss
13
 min read

BMI for Asian People: UK Thresholds Explained

Written by
Bolt Pharmacy
Published
29/10/2026
Last Updated
1/11/2026

BMI for Asian people is calculated the same way as for any adult, but the standard thresholds used to define healthy weight, overweight and obesity do not apply equally across all ethnic groups. Research shows that people of Asian heritage carry a greater proportion of visceral fat at any given BMI compared with people of European descent, raising their risk of type 2 diabetes and cardiovascular disease at lower body weights. UK guidance from NICE and the NHS therefore recommends adjusted BMI cut-offs for adults of Asian family background, with earlier intervention thresholds designed to prompt timely preventive action.

Summary: For people of Asian heritage, UK guidance recommends lower BMI thresholds of 23 kg/m² for increased risk and 27.5 kg/m² for obesity, rather than the standard 25 and 30 kg/m² used for European populations.

  • Standard BMI thresholds were derived from European populations and underestimate cardiometabolic risk in people of Asian heritage.
  • NICE and NHS guidance recommends a BMI of 23 kg/m² as the increased-risk threshold and 27.5 kg/m² as the obesity threshold for adults of Asian family background.
  • People of Asian heritage tend to accumulate more visceral fat at equivalent BMI values, which is more strongly linked to insulin resistance, type 2 diabetes and cardiovascular disease.
  • Waist circumference action thresholds are also lower for South Asian adults: 80 cm or above in women and 90 cm or above in men.
  • Pharmacological weight management options such as semaglutide and tirzepatide can be assessed using the adjusted BMI thresholds for eligible adults of Asian background.
  • A GP assessment combining adjusted BMI, waist circumference, blood pressure, fasting glucose and lipid profile provides the most complete picture of individual risk.
Measure Standard European Threshold Adjusted Asian Threshold Clinical Significance
BMI: increased risk begins 25 kg/m² 23 kg/m² Greater visceral fat at equivalent BMI drives earlier cardiometabolic risk
BMI: obesity equivalent 30 kg/m² 27.5 kg/m² Lower threshold prompts earlier preventive intervention, not weight stigma
Waist circumference: women 80 cm or above (initial action) 80 cm or above (South Asian) Same numeric value but applied at lower overall BMI context; risk accumulates earlier
Waist circumference: men 94 cm or above (initial action) 90 cm or above (South Asian) Lower action threshold reflects higher visceral fat burden at equivalent waist size
Waist-to-height ratio 0.5 or above (all adults) 0.5 or above (all adults) NICE-recommended marker of elevated risk; applies across ethnic groups
Weight-loss medicine eligibility (NICE) BMI 30 kg/m² or above BMI 27.5 kg/m² or above NICE supports adjusted thresholds for semaglutide and tirzepatide eligibility in Asian adults
Key associated conditions Type 2 diabetes, cardiovascular disease, hypertension Same conditions, arising at younger age and lower body weight Earlier monitoring and lifestyle intervention recommended in the 23 to 27.5 kg/m² range

Table of Contents

Why does BMI work differently for people of Asian heritage?

BMI works differently for people of Asian heritage because they carry more visceral fat at any given BMI than people of European descent, raising cardiometabolic risk at lower body weights. NICE guidance sets adjusted thresholds of 23 kg/m² and 27.5 kg/m² for these groups.

Standard BMI thresholds underestimate health risk in people of Asian heritage because the original reference ranges were derived predominantly from European populations, whose body composition differs meaningfully from that of South Asian, East Asian and South-East Asian groups.[1][2] BMI is calculated by dividing weight in kilograms by height in metres squared, producing a single number that does not distinguish between fat mass and lean mass, nor does it account for where fat is stored in the body.

Research consistently shows that people of Asian heritage tend to carry a greater proportion of body fat, particularly visceral fat around the abdominal organs, at any given BMI compared with people of European descent.[1][2] This matters clinically because visceral fat is more metabolically active and is more strongly associated with insulin resistance, cardiovascular disease and type 2 diabetes than subcutaneous fat stored beneath the skin.

In response to this evidence, a WHO expert consultation recommended lower action points specifically for Asian populations, and this work underpins current UK guidance.[1] NICE guidance and NHS resources acknowledge that the standard overweight threshold of 25 kg/m² and the obesity threshold of 30 kg/m² are not appropriate for adults of South Asian, Chinese or other Asian family background.[3][4] For these groups, a BMI of 23 kg/m² is considered the threshold at which increased health risk begins, and 27.5 kg/m² is used as the threshold equivalent to obesity. These adjusted cut-offs are intended to prompt earlier preventive action, not to stigmatise lower body weights.

For people of other minority ethnic backgrounds, including Black African, African-Caribbean and Middle Eastern heritage, current UK guidance does not assign specific alternative numeric thresholds in the same way. Clinical judgement, waist circumference and additional cardiometabolic risk assessment remain important for these groups, and a GP can advise on the most appropriate approach.

How is healthy weight assessed beyond standard BMI?

Waist circumference is the most clinically useful additional measure, with lower action thresholds for South Asian adults: 80 cm or above in women and 90 cm or above in men. A GP will typically combine this with BMI, blood pressure, fasting glucose and a lipid profile.

Waist circumference is one of the most clinically useful additional measures for assessing weight-related health risk, particularly in people of Asian heritage where BMI alone may be misleading. Waist circumference reflects central adiposity, meaning the accumulation of fat around the abdomen, which is the distribution pattern most strongly linked to cardiometabolic disease.

NICE guidance recommends that waist circumference be measured alongside BMI when assessing risk. For people of South Asian origin, action thresholds are lower than for European populations: a waist circumference of 80 cm or above in women and 90 cm or above in men of South Asian background is associated with increased risk.[3][7] For European populations, UK guidance identifies initial action levels of 80 cm or above in women and 94 cm or above in men, with higher-risk thresholds of 88 cm or above in women and 102 cm or above in men.[3][4] These figures reflect the same principle as the adjusted BMI cut-offs: that risk accumulates at lower absolute measurements in Asian groups.

Waist-to-height ratio is another practical tool. NICE recommends a ratio of 0.5 or above as a marker of elevated risk in adults. Body fat percentage, measured by methods such as dual-energy X-ray absorptiometry (DEXA) or bioelectrical impedance, provides a more direct assessment of adiposity but is not routinely available in primary care.

In practice, a GP assessment will typically combine BMI using ethnicity-adjusted thresholds, waist circumference, blood pressure, fasting glucose or HbA1c, and a lipid profile to build a fuller picture of an individual's cardiometabolic risk. No single measurement is sufficient on its own, and clinical judgement remains central to interpreting these figures in context.

Which health risks are linked to lower BMI cut-offs in Asian populations?

Type 2 diabetes, cardiovascular disease and hypertension are the conditions most strongly associated with lower BMI thresholds in Asian populations. South Asian adults in the UK develop type 2 diabetes at younger ages and lower body weights than White European populations.

Type 2 diabetes, cardiovascular disease and hypertension are the conditions most strongly associated with the lower BMI thresholds recommended for people of Asian heritage. Epidemiological data show that South Asian populations in the UK develop type 2 diabetes at younger ages and at lower body weights than White European populations, and that the condition is often more advanced at diagnosis.[9][10] This pattern is partly explained by greater insulin resistance at equivalent BMI values, driven by higher visceral fat accumulation.

Cardiovascular risk follows a similar pattern. Studies of UK South Asian communities have found higher rates of coronary heart disease compared with the general population, even after adjusting for conventional risk factors.[8] Central obesity, dyslipidaemia characterised by elevated triglycerides and low HDL cholesterol, and a tendency towards non-alcoholic fatty liver disease all contribute to this elevated risk profile.

Obstructive sleep apnoea has also been reported at lower BMI values in some East and South-East Asian populations, though the evidence base for this association is still developing and a GP or specialist can advise on individual risk.[11] Some research has linked central obesity to increased risk of certain cancers, including colorectal cancer, in Asian populations, but the evidence at BMI values below standard European intervention thresholds is not yet conclusive and should not be overstated.

It is important to note that these population-level patterns describe statistical associations and do not determine individual risk. A person of Asian heritage with a BMI between 23 and 27.5 kg/m² is not certain to develop any of these conditions, but the evidence supports earlier monitoring and lifestyle intervention in this range. Anyone with concerns about their personal risk should speak to their GP, who can arrange appropriate investigations.

How can you manage your weight using the right targets for your background?

Using ethnicity-adjusted BMI and waist circumference targets gives a more accurate basis for weight management goals and decisions about when to seek support. Lifestyle intervention is first-line, with pharmacological options such as semaglutide or tirzepatide available where criteria are met using adjusted thresholds.

Using ethnicity-adjusted BMI thresholds and waist circumference targets gives people of Asian heritage a more accurate framework for setting weight management goals and deciding when to seek support. If your BMI is above 23 kg/m² or your waist circumference exceeds the lower action thresholds for your background, it is worth discussing this with your GP, who can assess your overall cardiometabolic risk and recommend appropriate next steps. Eligible adults may also benefit from an NHS Health Check, which assesses cardiovascular and metabolic risk and can prompt onward referral.

Lifestyle interventions remain the foundation of weight management for all population groups. A diet that reduces overall calorie intake while maintaining nutritional adequacy, combined with regular physical activity, is recommended by NICE as the first-line approach. For people of South Asian heritage in particular, dietary patterns that limit refined carbohydrates and saturated fats may be especially beneficial given the tendency towards insulin resistance. NHS weight management programmes, including the NHS Diabetes Prevention Programme for those at high risk of type 2 diabetes, are available to eligible individuals and are designed to be culturally sensitive.[14][15]

Where lifestyle measures are insufficient, pharmacological treatment may be considered. NICE technology appraisals have recommended medicines such as semaglutide (Wegovy) and tirzepatide (Mounjaro) for chronic weight management in adults meeting specific criteria.[12][13] For adults of Asian family background, NICE guidance supports applying the adjusted BMI thresholds of 23 and 27.5 kg/m² when assessing eligibility. Access to these medicines on the NHS typically occurs through specialist weight-management services and is subject to local Integrated Care Board commissioning decisions, so availability may vary. Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support, where clinically appropriate options may be discussed.

If you are concerned about your weight or related health risks, contact your GP in the first instance. For urgent symptoms such as chest pain or severe breathlessness, call 999. For non-emergency health advice, NHS 111 is available around the clock.

Scientific References

  1. .
  2. .
  3. .
  4. .
  5. .
  6. .
  7. .
  8. .
  9. .
  10. .
  11. .
  12. .
  13. .
  14. .
  15. .

Frequently Asked Questions

What BMI is considered overweight for people of Asian heritage in the UK?

For adults of Asian family background, NICE and NHS guidance recommends a BMI of 23 kg/m² as the threshold for increased health risk and 27.5 kg/m² as the threshold equivalent to obesity, compared with 25 and 30 kg/m² for European populations.

Why are BMI thresholds lower for Asian people?

People of Asian heritage tend to carry a greater proportion of visceral fat around the abdominal organs at any given BMI compared with people of European descent, which is more strongly linked to insulin resistance, type 2 diabetes and cardiovascular disease. Lower thresholds are used to prompt earlier preventive action.

Can people of Asian heritage access weight management medicines using adjusted BMI thresholds?

Yes. NICE guidance supports using the adjusted BMI thresholds of 23 kg/m² and 27.5 kg/m² when assessing eligibility for pharmacological weight management treatments such as semaglutide or tirzepatide in adults of Asian family background. Access on the NHS is typically through specialist weight management services, subject to local commissioning.


Disclaimer & Editorial Standards

The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.

The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.

Any third-party brands or services referenced on this site are included for informational purposes only; we are entirely independent and have no affiliation, partnership, or collaboration with any companies mentioned.